88 related articles for article (PubMed ID: 164699)
1. Somatic hybridization and oncogenesis; (Mechanism of formation of malignant tumors and metastases by the action of antilymphocytic serum).
Mekler LB; Artamonova SI; Bodyagin DA; Drize OB; Mkheidze DM; Osechinskii IV; Solenov VN
Sov J Dev Biol; 1975 May; 5(3):201-19. PubMed ID: 164699
[TBL] [Abstract][Full Text] [Related]
2. [Somatic hybridization and oncogenesis: induction of tumors in mice by administration of mixtures of cells of the homologous organs and their hybrids].
Mekler LB; Artamonova SI; Bodiagin DA; Osechinskiĭ IV
Ontogenez; 1976; 7(3):246-54. PubMed ID: 194198
[TBL] [Abstract][Full Text] [Related]
3. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
Dennert G; Anderson CG; Warner J
J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
[TBL] [Abstract][Full Text] [Related]
4. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
Russell PS; Chase CM; Burton RC
J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
8. Development of tumors as a result of graft-versus-host reaction.
Cornelius EA
Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
[No Abstract] [Full Text] [Related]
9. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
Klein E; Klein G
Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
[No Abstract] [Full Text] [Related]
10. Studies on the mechanism of chronic graft rejection in mice.
Végh P; Jánossy T; Erdös E
Acta Chir Hung; 1983; 24(4):329-37. PubMed ID: 6367324
[TBL] [Abstract][Full Text] [Related]
11. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
Lake P; Sabbadini E; Sehon AH
Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
[TBL] [Abstract][Full Text] [Related]
12. Serum Ia levels during tumor growth in mice and humans.
Sandrin MS; Henning MM; Vaughan HA; McKenzie IF; Parish CR
J Natl Cancer Inst; 1981 Feb; 66(2):279-83. PubMed ID: 6935478
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
McKenzie IF; Snell GD
Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
[No Abstract] [Full Text] [Related]
14. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
[TBL] [Abstract][Full Text] [Related]
15. Fetal liver cell transplantation in various murine models.
Sanhadji K; Touraine JL; Aitouche A; Vicari A; Chargui J; Goillot E
Bone Marrow Transplant; 1992; 9 Suppl 1():77-82. PubMed ID: 1504674
[TBL] [Abstract][Full Text] [Related]
16. Fusion-induced malignancy? A preliminary study. (a challenge to today's common wisdom).
Munzarová M; Lauerová L; Kovarík J; Rejthar A; Brezina V; Kellnerová R; Kovarík A
Neoplasma; 1992; 39(2):79-86. PubMed ID: 1528312
[TBL] [Abstract][Full Text] [Related]
17. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
18. Effect of immunotherapy with allogeneic lymphokine-activated killer cells and recombinant interleukin 2 on established pulmonary and hepatic metastases in mice.
Shiloni E; Lafreniere R; Mulé JJ; Schwarz SL; Rosenberg SA
Cancer Res; 1986 Nov; 46(11):5633-40. PubMed ID: 3489526
[TBL] [Abstract][Full Text] [Related]
19. Is immunosuppression at the tumor site mechanism of evasion of a systemic response?
Karakousis CP; Sharma S; Brooks SP
J Med; 2003; 34(1-6):3-14. PubMed ID: 17682306
[TBL] [Abstract][Full Text] [Related]
20. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
Isakov N; Feldman M; Segal S
Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
